Lavender (High Elevevation) Essential Oil

Botanical Name:
Lavandula angustifolia
Country of Origin:
Plant Part:
Flowering Tops
Distillation Method:
Certified Organic
Overall Profile
Primary Constituents
linalyl acetate
beta caryophyllene
beta cis ocimene
geranyl acetate
  • 1oz -
  • 4oz -
  • 8oz -
  • 16oz -
  • 1Kg -
  • Sample -

Wholesale Pure Lavender Essential Oil

100% pure Lavender essential oil steam distilled from the flowering tops of plants organically grown in the high elevation regions of France – a region known for the world's most fragrant Lavenders. This is an especially nice oil, with a beautiful, complex aroma. Our High Elevation Lavender Oil is available from sample size up to 1 kg or more.


Of the many Lavender essential oil varieties, it is typically the French Lavenders from mountainous regions that are held in the highest regard. The climate is perfect, and the higher altitude lends to lower distillation temperatures. This Lavender is both aromatically and therapeutically just about perfect. It is steam distilled from the flowering tops of plants naturally grown in the high elevation regions of France - a region known for the world's most fragrant Lavenders. Lavender grown at high altitudes naturally produces more 'Linalool', a component of the essential oil found to reduce stress and improve sleep. This High Alpine variety is distilled from closely cared for plants with finely tuned harvesting and distillation times, temperatures and pressures. We consider this to be the sweetest of the three varieties of Lavendula angustifolia.

Aromatherapy Notes

Much of the therapeutic calming action of Lavender essential oil is attributed to its high Linalool levels. Whether sprinkled on bedsheets to aid sleep, inhaled during times of stress to help lower blood pressure and 'take the edge off', or added to a bath to soothe aching muscles and relieve anxiety, Lavender can inhibit sympathetic or parasympathetic nervous system function to assist in reducing unproductive stress of any kind.

Therapeutic Properties

The latest research on Lavender essential oil was published by researchers at the Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria. This was a placebo controlled, randomized, double blind study investigating the effects of a pill containing 80 milligrams of Lavender essential oil. The pill was evaluated primarily for its effects at reducing anxiety and improving sleep. Study participants consumed one of these capsules daily for 10 weeks. In every category examined, the lavender preparation exceeded the efficacy of the placebo. It was able to improve the quality of sleep, reduce anxiety, and actually improve the overall perception of health and well-being for the users. The researchers concluded the Lavender-containing capsule "is both efficacious and safe for the relief of anxiety disorder...It has a clinically meaningful anxiolytic (anxiety-relieving) effect and alleviates anxiety related disturbed sleep.” In a study by the same group of researchers, Lavender oil was compared not to a placebo, but to Lorazepam, a "high potency benzodiazepine drug." The conclusion noted: "our results demonstrate that [...the Lavender capsule...] is as effective as Lorazepam in adults with GAD (general anxiety disorder)." It was also noted that one of the wonderful features of the natural substance is that it has no potential for abuse, unlike the benzodiazepines (such as Valium). Lavender has been favorably compared to these anxiety-relieving drugs in many studies over the last decade and is also noted in its ability to reduce aggressive tendencies.1

Application and Use


Lavender essential oil is considered among the safest oils in aromatherapy, and can be applied undiluted to the skin. Has a wide range of uses. Safe for children; can be taken internally.


1 Kasper, Siegfried, et al. “Silexan, an Orally Administered Lavandula Oil Preparation, Is Effective in the Treatment of 'Subsyndromal' Anxiety Disorder: a Randomized, Double-Blind, Placebo Controlled Trial.” International Clinical Psychopharmacology, vol. 25, no. 5, 2010, pp. 277–287., doi:10.1097/yic.0b013e32833b3242.